Pathology Doctors in Janesville, WI Accepting Medicare

6 Pathology doctors found. Showing 1 - 6

Dr. Michael J Strassman, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6000

Sandra Saldana Cervantes, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6761    Fax: 608-756-6572

Dr. Steven Salisbury, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6000

Dr. David Vincent Baewer, MD PHD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6761    Fax: 608-756-6572

Thomas S Haas, DO Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6000

Dr. Sonya Naryshkin, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6000

News Archive

Research study links high-fructose diet to increased blood pressure in men

A high-fructose diet raises blood pressure in men, while a drug used to treat gout seems to protect against the blood pressure increase, according to research reported at the American Heart Association's 63rd High Blood Pressure Research Conference.

Cosmetic surgery industry continues to grow in the U.S., says AACS survey

A procedural survey conducted by the American Academy of Cosmetic Surgery says more than 17 million cosmetic surgery procedures were performed in the United States in 2009.

Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain

Eli Lilly and Company has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for Cymbalta (duloxetine HCl) for the management of chronic pain.

New blood pressure measurement device may enable doctors to treat patients more effectively

In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients' blood pressure is measured.

Transplantation of periorbital tissues may be feasible alternative to protect vision in facial transplant patients

Transplantation of the periorbital tissues-the area surrounding the eyes-is a "technically feasible" alternative to protect a functioning eye in some patients being considered for facial transplant, according to a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.

Read more Medical News

› Verified 4 days ago